医学信息
醫學信息
의학신식
Medical Information
2015年
37期
20-20,21
,共2页
钟杰林%蔡迎%金成浩%苏啸天
鐘傑林%蔡迎%金成浩%囌嘯天
종걸림%채영%금성호%소소천
股骨颈骨折%全髋关节置换%隐性失血%低分子肝素%利伐沙班
股骨頸骨摺%全髖關節置換%隱性失血%低分子肝素%利伐沙班
고골경골절%전관관절치환%은성실혈%저분자간소%리벌사반
Femoral neck fractures%Total hip arthroplasty%Hidden blood loss%Low molecular heparin%Rivaroxaban
目的：对比观察低分子肝素与利伐沙班对老年股骨颈骨折行全髋关节置换术后隐性失血的影响。方法回顾分析我院骨科2010年1月~2014年6月所有行全髋关节置换的老年股骨颈骨折患者65例,按照术后应用的抗凝药物不同分为两组,其中低分子肝素31例,利伐沙班34例,观察两组术后总失血量、显性失血量并计算隐性失血量。结果低分子肝素组失血总量为(715.7±192.6)ml,其中显性失血量(251.5±84.3)ml、隐性失血量(464.2±134.5)ml；利伐沙班组失血总量为(600.4±203.8)ml,其中显性失血量(242.6±95.4)ml、隐性失血量(357.8±115.2)ml。两组比较,失血总量及隐性失血量差异有统计学意义(<0.05)。结论利伐沙班较低分子肝素可减少老年股骨颈骨折行全髋关节置换术患者术后隐性失血。
目的：對比觀察低分子肝素與利伐沙班對老年股骨頸骨摺行全髖關節置換術後隱性失血的影響。方法迴顧分析我院骨科2010年1月~2014年6月所有行全髖關節置換的老年股骨頸骨摺患者65例,按照術後應用的抗凝藥物不同分為兩組,其中低分子肝素31例,利伐沙班34例,觀察兩組術後總失血量、顯性失血量併計算隱性失血量。結果低分子肝素組失血總量為(715.7±192.6)ml,其中顯性失血量(251.5±84.3)ml、隱性失血量(464.2±134.5)ml；利伐沙班組失血總量為(600.4±203.8)ml,其中顯性失血量(242.6±95.4)ml、隱性失血量(357.8±115.2)ml。兩組比較,失血總量及隱性失血量差異有統計學意義(<0.05)。結論利伐沙班較低分子肝素可減少老年股骨頸骨摺行全髖關節置換術患者術後隱性失血。
목적：대비관찰저분자간소여리벌사반대노년고골경골절행전관관절치환술후은성실혈적영향。방법회고분석아원골과2010년1월~2014년6월소유행전관관절치환적노년고골경골절환자65례,안조술후응용적항응약물불동분위량조,기중저분자간소31례,리벌사반34례,관찰량조술후총실혈량、현성실혈량병계산은성실혈량。결과저분자간소조실혈총량위(715.7±192.6)ml,기중현성실혈량(251.5±84.3)ml、은성실혈량(464.2±134.5)ml；리벌사반조실혈총량위(600.4±203.8)ml,기중현성실혈량(242.6±95.4)ml、은성실혈량(357.8±115.2)ml。량조비교,실혈총량급은성실혈량차이유통계학의의(<0.05)。결론리벌사반교저분자간소가감소노년고골경골절행전관관절치환술환자술후은성실혈。
Objective To compare the ef ects of low molecular heparin and rivaroxaban in hidden blood loss after the operation of femoral neck fracture in the elderly. Methods We retrospectively studied 65 patients with femoral neck fracture in the elderly treated with total hip arthroplasty (THA) between January 2010 and June 2014, 34 were assigned into the observation group of rivaroxaban and 31 into the control group of low molecular heparin, calculated the hidden blood in both groups by observing the total blood loss and dominant blood loss after operation. Results The total blood loss was(715.7±192.6)ml, the dominant blood loss was(251.5±84.3)ml, the hidden blood was(464.2±134.5)ml in group of low molecular heparin, and there was (600.4±203.8)ml of total blood loss and (242.6±95.4)ml of dominant blood loss and (357.8±115.2)ml of hidden blood loss in group of rivaroxaban , the dif erence was significant ( <0.05). Conclusion The ef ect of rivaroxaban on hidden blood after THA treatment for femoral neck fractures in the elderly was lit le than low molecular heparin.
